Back

Association of P2Y12 inhibitor pretreatment strategy with short and long term ischemic and bleeding outcomes in NSTE-ACS patients

1 September 2024 (17:00 - 17:50)
Organised by: Logo
Congress Presentation Part of: Bleeding and antiplatelet strategies in acute coronary syndromes Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speakers

Photo
Doctor Kivanc Keskin

Hakkari Yuksekova State Hospital, Hakkari (Turkiye)

Photo
Associate Professor Ali Nazmi Calik

Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Center, Istanbul (Turkiye)

7 More presentations in this session

Presentation thumbnail
Temporal trends in major bleeding after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction from 2003 to 2017: the Western Denmark Heart Registry
Doctor P. Thrane (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Thirty days clinical outcomes following stent implantation with aspirin-free prasugrel monotherapy in non-ST segment elevation myocardial infarction. Interim report from ASET-Japan pilot study
Doctor K. Miyashita (Galway, IE)
Abstract Slides Video
Presentation thumbnail
Ticagrelor vs. clopidogrel in ST elevation myocardial infarction patients with hemoglobin > 160
Doctor T. Gu (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Safety and effectiveness of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the SPUM-ACS study
Doctor F. Wenzl (Zurich, CH) Doctor F. Bruno (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Differential prognostic significance of platelet reactivity based on ischemic risk after percutaneous coronary intervention
Assistant Professor K. Jeon (Seongnam, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Bleeding and antiplatelet strategies in acute coronary syndromes

The Event

Event poster

ESC Congress 2024

1 September 2024 17:00 CET
You may be interested in
thumbnail
Congress Presentation
Impact of pretreatment with P2Y12 receptor inhibitors on type 4a myocardial infarction and bleeding in patients with non-ST-segment elevation myocardial infarction: a propensity score matching study
thumbnail
Congress Presentation
Effect of P2Y12 pretreatment on angiographic findings and in-hospital mortality in patients with ST-elevation myocardial infarction
thumbnail
Congress Presentation
Prognostic implications of p2y12 inhibitor pre-treatment in non-st segment elevation acute coronary syndromes undergoing late invasive strategy - a national registry analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources